Biglycan anticorps (Precursor)
Aperçu rapide pour Biglycan anticorps (Precursor) (ABIN646099)
Antigène
Voir toutes Biglycan (BGN) AnticorpsReactivité
Hôte
Conjugué
Application
-
-
Épitope
- Precursor
-
Réactivité croisée
- Humain, Souris, Rat (Rattus), Chien
-
Attributs du produit
- Goat Anti-Biglycan Preproprotein
-
Immunogène
- Peptide with sequence C-DRLAIQFGNYKK, from the C Terminus of the protein sequence according to NP_001702.1.
-
-
-
-
Indications d'application
- Immunoassay (ELISA, Western blotting): 1:5,000-1:10,000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- Biglycan (BGN)
-
Autre désignation
- Biglycan Preproprotein
-
Sujet
- Synonyms: small leucine-rich protein 1A, dermatan sulphate proteoglycan I, bone/cartilage proteoglycan-I, SLRR1A, PGI, PG-S1, DSPG1, BGN, biglycan, Biglycan Preproprotein
-
ID gène
- 633
-
NCBI Accession
- NP_001702
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-